4,039 Shares in Xylem Inc (XYL) Purchased by We Are One Seven LLC

We Are One Seven LLC acquired a new stake in shares of Xylem Inc (NYSE:XYL) in the third quarter, HoldingsChannel reports. The fund acquired 4,039 shares of the industrial products company’s stock, valued at approximately $322,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Parnassus Investments CA grew its position in Xylem by 1.2% in the 2nd quarter. Parnassus Investments CA now owns 6,171,524 shares of the industrial products company’s stock worth $415,837,000 after purchasing an additional 74,982 shares during the last quarter. Janus Henderson Group PLC grew its position in Xylem by 38.1% in the 2nd quarter. Janus Henderson Group PLC now owns 3,189,273 shares of the industrial products company’s stock worth $214,898,000 after purchasing an additional 880,125 shares during the last quarter. Bank of America Corp DE grew its position in Xylem by 8.3% in the 2nd quarter. Bank of America Corp DE now owns 2,721,844 shares of the industrial products company’s stock worth $183,398,000 after purchasing an additional 207,898 shares during the last quarter. USS Investment Management Ltd grew its position in Xylem by 43.7% in the 2nd quarter. USS Investment Management Ltd now owns 2,615,320 shares of the industrial products company’s stock worth $176,220,000 after purchasing an additional 795,628 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its position in Xylem by 5.8% in the 2nd quarter. Bank of New York Mellon Corp now owns 2,006,332 shares of the industrial products company’s stock worth $135,187,000 after purchasing an additional 109,516 shares during the last quarter. Hedge funds and other institutional investors own 85.85% of the company’s stock.

Xylem stock opened at $69.77 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.43 and a debt-to-equity ratio of 0.86. The company has a market capitalization of $14.35 billion, a PE ratio of 29.07, a P/E/G ratio of 1.52 and a beta of 1.22. Xylem Inc has a 12-month low of $62.24 and a 12-month high of $82.44.

Xylem (NYSE:XYL) last posted its quarterly earnings data on Tuesday, July 31st. The industrial products company reported $0.73 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.02. The business had revenue of $1.32 billion during the quarter, compared to analysts’ expectations of $1.28 billion. Xylem had a net margin of 7.39% and a return on equity of 19.04%. The business’s revenue was up 13.1% on a year-over-year basis. During the same period last year, the firm posted $0.59 earnings per share. As a group, sell-side analysts anticipate that Xylem Inc will post 2.91 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 7th. Stockholders of record on Thursday, November 1st will be issued a $0.21 dividend. This represents a $0.84 annualized dividend and a dividend yield of 1.20%. The ex-dividend date is Wednesday, October 31st. Xylem’s dividend payout ratio (DPR) is presently 35.00%.

XYL has been the subject of several recent analyst reports. Raymond James initiated coverage on shares of Xylem in a research report on Wednesday, September 5th. They issued an “outperform” rating and a $90.00 target price for the company. Vertical Research cut shares of Xylem from a “hold” rating to a “sell” rating in a research report on Monday, October 8th. Stifel Nicolaus upped their target price on shares of Xylem from $75.00 to $80.00 and gave the stock a “hold” rating in a research report on Wednesday, August 1st. Robert W. Baird restated a “hold” rating and issued a $80.00 target price on shares of Xylem in a research report on Wednesday, August 1st. Finally, Oppenheimer restated a “buy” rating on shares of Xylem in a research report on Tuesday, July 31st. Two research analysts have rated the stock with a sell rating, four have given a hold rating and nine have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $81.75.

In other news, SVP Kairus Tarapore sold 18,800 shares of the stock in a transaction that occurred on Friday, August 3rd. The shares were sold at an average price of $75.17, for a total value of $1,413,196.00. Following the completion of the transaction, the senior vice president now directly owns 31,580 shares in the company, valued at $2,373,868.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Colin R. Sabol sold 17,161 shares of the stock in a transaction that occurred on Monday, September 17th. The shares were sold at an average price of $81.37, for a total transaction of $1,396,390.57. Following the completion of the transaction, the insider now owns 41,988 shares of the company’s stock, valued at $3,416,563.56. The disclosure for this sale can be found here. Insiders sold 49,284 shares of company stock valued at $3,839,982 over the last quarter. Insiders own 0.81% of the company’s stock.

Xylem Profile

Xylem Inc engages in the design, manufacture, and service of engineered solutions for the water and wastewater applications. It operates through three segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps, and controls and systems, as well as filtration, disinfection, and biological treatment equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation, treatment, and testing of water and wastewater applications.

See Also: Average Daily Trade Volume – What It Means In Stock Trading

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc (NYSE:XYL).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply